Search
Recent Posts
- ChangingAging.org Redesign -- Please Bookmark!
- Disaster in Buffalo
- Power Up Friday
- Blanchard WinsDays
- Kevin Frick writes...
- Monkhouse Monday
- Getting Closer!
- Blanchard WinsDays
- Power Up Friday
- My Pick for Health and Human Services
- Understanding Health Care Reform
- Facts Are Stubborn Things: Social Security Edition
- Monkhouse Monday
- Localism is Coming
- Krugman Can't Wait...
Recent Comments
- Arnold on
It Takes A Team: To Fight Generics
Category Archives
- AGING 100
- Aging
- Culture
- Dementia
- Eden Alternative
- Erickson School
- Green House
- Health Policy
- Longevity
- Media
- Rockets
Monthly Archives
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
- August 2007
Subscribe to this blog's feed
Announcements

Blog Data
« Ripple | Main | One Womans's Thoughts on Aging »
November 17, 2007 |Permalink |Comments (1)
It Takes A Team: To Fight Generics
Generic medications are safe, cost-effective substitutes for expensive brand-name drugs.
Switching to generics saves money for individuals and for the health care system as a whole.
Naturally, the big drug companies see generics as a threat to their profits.
So...
RESEARCH TRIANGLE PARK, NC -- 10/25/07 -- Branded pharmaceutical companies plan for generic competition years in advance. A solid head start isn't enough, though -- to build the best counter-generics plans, companies need contributions from personnel in different departments.Involving multiple people is key to prolonging brand life, according to a new study by Cutting Edge Information (http://www.PharmaGenerics.com). While marketing teams almost always contribute to counter-generics planning, stakeholders from other groups ensure that strategies include as many viable options as possible. They also help to establish contingency plans.
Those with strong stomachs can read the whole pile of rubbish here.
Comments ( 1)
The Medicare Part D program (as confusing as it is)creates for the consumer a strong economic incentive to use generics. In 2008 many more of the stand alone plans are requiring step therapy as a prerequisite for reimbursement. Generics are cheaper and help the consumer spend less trying to avoid reaching the gaps in coverage. For details of the 2008 Part D plan bloggers can visit www.takingcareofmomanddad.net and click on the Medciare Part D button.
The doughnut hole starts at :
$2,510- $5,726.25. A gap of $3,216.25 out of pocket. That is a lot of cash and helps to encourage use of generics.